NCT04282070 2021-12-21
SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
Jiangsu HengRui Medicine Co., Ltd.
Ludwig-Maximilians - University of Munich
Atlantic Health System
Wakayama Medical University
e-Therapeutics PLC
US Oncology Research